AstraZeneca said that its vaccine developed with the University of Oxford appeared to offer limited protection against mild disease caused by the South African variant of COVID-19
#News #CovidVaccine #AstraZeneca
Subscribe:…
Oxford COVID shot ‘less effective on South Africa variant’
0 Comments
Most Voted